Ozempic accidentally became a cultural phenomenon. The drug, first delivered to diabetes patients in 2017, had a huge impact ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

This week, medication savings platform GoodRx announced a partnership with Novo Nordisk – the company behind Ozempic and ...

The maker of Ozempic is slashing prices for U.S. patients who pay cash, a major shift in the fast-growing market for the drug ...

The Ozempic price cut could appease US President Donald Trump, who has pushed for drug companies to lower their prices.

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...

After Novo Nordisk revealed Ozempic will retail for half-price at 70,000 pharmacies throughout the US, people are questioning ...

Americans can now purchase Ozempic at half the cost if paying in cash, thanks to Novo Nordisk's latest announcement.